Full text is available at the source.
Abstract
The review synthesizes evidence on the interaction between HIV and gut microbiota, emphasizing its importance in managing HIV infection.
- HIV infection is associated with gut microbiota disruption and mucosal immune dysfunction, potentially leading to chronic inflammation.
- Different classes of antiretroviral therapy (ART) may have varying effects on the composition of the intestinal microbiome.
- The microbiota-gut-brain axis could play a role in the development of HIV-associated neurocognitive disorders (HAND).
- Microbiota-targeted interventions, such as probiotics and dietary strategies, show potential for therapeutic application in people living with HIV.
- The review identifies critical knowledge gaps and suggests research priorities for future microbiota-informed strategies in HIV management.
Simplified